Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sota Kato

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2020
Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-<i>α</i> StabilizationHiroki Takano, Jun-Ichi Yamaguchi, Sota Kato, et al.
Journal of Diabetes & Metabolism|December 10, 2013
Comparison of the Development Diabetic Induced Renal Disease in Strains of Goto-Kakizaki RatsNaoki Kojima, Tiffani N Slaughter, Adrienne Paige, et al.
Biochemical and Biophysical Research Communications|October 6, 2005
Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytesTsuyoshi Goto, Nobuyuki Takahashi, Sota Kato, et al.
Scientific Reports|December 2, 2022
Classification and visual explanation for COVID-19 pneumonia from CT images using triple learningSota Kato, Masahiro Oda, Kensaku Mori, et al.
Physiological Reports|July 15, 2015
Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S ratsNaoki Kojima, Jan M Williams, Tiffani N Slaughter, et al.
Life Sciences|August 30, 2011
Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetesAtsushi Tajima, Takashi Hirata, Kazuo Taniguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2019
TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the LiverSota Kato, Nagahiro Ochiai, Hiroki Takano, et al.
European Journal of Pharmacology|September 5, 2018
TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlationSota Kato, Noriko Takayama, Hiroki Takano, et al.
Nature Communications|January 6, 2021
Crystallization-induced mechanofluorescence for visualization of polymer crystallizationSota Kato, Shigeki Furukawa, Daisuke Aoki, et al.
American Journal of Nephrology|September 4, 2018
Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy VolunteersAya Shinfuku, Toshiharu Shimazaki, Masanori Fujiwara, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2020
Downregulation of CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes by Prolyl Hydroxylase Domain 2 Inhibitors via Hypoxia-Inducible Factor-<i>α</i> StabilizationHiroki Takano, Jun-Ichi Yamaguchi, Sota Kato, et al.
Journal of Diabetes & Metabolism|December 10, 2013
Comparison of the Development Diabetic Induced Renal Disease in Strains of Goto-Kakizaki RatsNaoki Kojima, Tiffani N Slaughter, Adrienne Paige, et al.
Biochemical and Biophysical Research Communications|October 6, 2005
Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytesTsuyoshi Goto, Nobuyuki Takahashi, Sota Kato, et al.
Scientific Reports|December 2, 2022
Classification and visual explanation for COVID-19 pneumonia from CT images using triple learningSota Kato, Masahiro Oda, Kensaku Mori, et al.
Physiological Reports|July 15, 2015
Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S ratsNaoki Kojima, Jan M Williams, Tiffani N Slaughter, et al.
Life Sciences|August 30, 2011
Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetesAtsushi Tajima, Takashi Hirata, Kazuo Taniguchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2019
TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the LiverSota Kato, Nagahiro Ochiai, Hiroki Takano, et al.
European Journal of Pharmacology|September 5, 2018
TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlationSota Kato, Noriko Takayama, Hiroki Takano, et al.
Nature Communications|January 6, 2021
Crystallization-induced mechanofluorescence for visualization of polymer crystallizationSota Kato, Shigeki Furukawa, Daisuke Aoki, et al.
American Journal of Nephrology|September 4, 2018
Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy VolunteersAya Shinfuku, Toshiharu Shimazaki, Masanori Fujiwara, et al.
Pageof 3